ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,906Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 682

$1.57M Total Retail Price of All Prescriptions

Rank: 29 out of 682

984 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 984 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 984 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 23,931 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,465 1,026 S3 1 1
SIMVASTATIN 1,196 1,010 2 4
LISINOPRIL 1,035 856 3 2
FUROSEMIDE 989 830 4 7
LEVOTHYROXINE SODIUM 872 778 5 3
AMLODIPINE BESYLATE 847 747 6 6
METOPROLOL TARTRATE 809 672 7 10
OMEPRAZOLE 674 543 8 5
POTASSIUM CHLORIDE 559 449 9 14
METFORMIN HCL 544 395 10 8
MELOXICAM 510 459 11 27
GABAPENTIN 504 368 12 9
TRAMADOL HCL 448 373 13 26
WARFARIN SODIUM 423 376 14 13
DONEPEZIL HCL 407 381 15 30
TRAZODONE HCL 401 314 16 38
ATORVASTATIN CALCIUM 386 325 17 11
CITALOPRAM HBR 353 269 18 17
RANITIDINE HCL 337 246 19 28
HYDROCHLOROTHIAZIDE 315 265 20 12
METOPROLOL SUCCINATE 301 262 21 16
AZITHROMYCIN 295 230 22 39
NAMENDA 287 263 23 41
BUSPIRONE HCL 283 219 24 102
CLOPIDOGREL 280 236 25 25
PRAVASTATIN SODIUM 263 225 26 15
CRESTOR 255 200 27 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 254 202 28 34
ZOLPIDEM TARTRATE 246 202 29 21
LOSARTAN POTASSIUM 240 214 30 20
PANTOPRAZOLE SODIUM 239 168 31 29
ISOSORBIDE MONONITRATE ER 235 150 32 31
SERTRALINE HCL 231 218 33 24
LANTUS 229 177 34 55
NEXIUM 228 173 35 19
PROMETHAZINE HCL 204 116 R 36 54
TAMSULOSIN HCL 203 163 37 33
ALLOPURINOL 186 171 38 32
ATENOLOL 171 127 39 18
GLIPIZIDE 168 132 40 61
ALENDRONATE SODIUM 168 153 40 37
CARVEDILOL 162 116 42 23
PAROXETINE HCL 161 105 43 53
PLAVIX 160 135 44 35
ESCITALOPRAM OXALATE 156 150 45 73
LOSARTAN-HYDROCHLOROTHIAZIDE 156 133 45 56
DIGOXIN 154 146 47 46
DIOVAN 151 130 48 42
SPIRIVA 144 118 49 49
ROPINIROLE HCL 141 104 50 71
CIPROFLOXACIN HCL 140 115 51 58
TAMIFLU 136 118 52 332
KLOR-CON M20 136 124 52 67
POLYETHYLENE GLYCOL 3350 136 95 52 44
CLONIDINE HCL 126 93 55 48
GENERLAC 124 107 56 270
VENLAFAXINE HCL 123 78 57 225
MIRTAZAPINE 121 101 58 52
JANUVIA 119 96 59 62
LANTUS SOLOSTAR 118 88 60 114
METFORMIN HCL ER 104 98 61 68
AMITRIPTYLINE HCL 101 90 R 62 50
PRAMIPEXOLE DIHYDROCHLORIDE 100 46 63 190
LEVOFLOXACIN 100 76 63 70
NOVOLIN R 99 70 65 167
PROAIR HFA 97 71 66 45
CYCLOBENZAPRINE HCL 96 75 R 67 65
SPIRONOLACTONE 95 83 68 64
QUETIAPINE FUMARATE 94 84 69 87
LIPITOR 94 68 69 92
RISPERIDONE 94 87 69 82
FLUOXETINE HCL 93 68 72 60
FAMOTIDINE 86 81 73 99
PHENYTOIN SODIUM EXTENDED 85 83 74 140
CYMBALTA 85 67 74 51
ENALAPRIL MALEATE 85 69 74 91
ADVAIR DISKUS 83 49 77 47
VYTORIN 83 71 77 145
ZETIA 77 55 79 69
VENLAFAXINE HCL ER 77 63 79 119
LYRICA 77 43 79 78
ALBUTEROL SULFATE 74 55 82 156
DILTIAZEM ER 74 63 82 136
DIOVAN HCT 73 57 84 109
PREMARIN 73 61 R 84 132
PREDNISONE 73 56 84 40
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 56 87 103
OXYBUTYNIN CHLORIDE 71 57 88 173
LANSOPRAZOLE 71 61 88 85
GEMFIBROZIL 71 59 88 122
LOVASTATIN 71 50 88 66
CEPHALEXIN 70 59 92 128
SYMBICORT 69 59 93 117
CELEBREX 69 60 93 80
NIASPAN 68 41 95 133
HYDRALAZINE HCL 65 54 96 74
TERAZOSIN HCL 65 64 96 171
METOLAZONE 64 50 98 229
THEOPHYLLINE ANHYDROUS 63 39 99 153
LEVETIRACETAM 63 38 99 125
TRIAMTERENE-HCTZ 61 50 101 57
FINASTERIDE 60 48 102 131
SINGULAIR 59 40 103 63
NOVOLOG 59 42 103 129
TOPIRAMATE 59 19 103 150
FOSINOPRIL SODIUM 58 57 106 275
NISOLDIPINE 58 46 106 315
NITROSTAT 58 42 106 161
TRICOR 58 38 106 94
NYSTATIN 57 47 110 95
MECLIZINE HCL 57 54 110 124
DICYCLOMINE HCL 56 44 112 214
PRIMIDONE 56 56 112 228
DIVALPROEX SODIUM 55 25 114 84
NIFEDIPINE ER 54 32 115 144
CARISOPRODOL 54 15 R 115 146
DOXAZOSIN MESYLATE 54 54 115 96
XOPENEX 52 36 118 461
CLONAZEPAM 52 52 118 194
GLIMEPIRIDE 51 40 120 43
NAPROXEN 50 35 121 97
AMLODIPINE BESYLATE-BENAZEPRIL 50 47 121 77
MONTELUKAST SODIUM 50 39 121 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.